Mineral Metabolism and Polycystic Ovary Syndrome and Metabolic Risk Factors: A Mendelian Randomization Study

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2024 Feb 17

PMID 38366089

Authors

Jiayan Shen

Li Xu

Xiaoyun Wu

Yang Ding

Affiliations

Soon will be listed here.

Abstract

Observational investigations recommend that mineral supplements were associated with a higher risk of polycystic ovary syndrome (PCOS) and its risk factors (insulin resistance, hyperandrogenism, and obesity), but the relationship with risk of PCOS, hyperandrogenism, obesity, and insulin resistance was unclear. This study was to investigate the potential causal impact of genetically predicted levels of magnesium (Mg), calcium (Ca), selenium (Se), zinc (Zn), iron (Fe), and omega-3 (ω-3) on polycystic ovary syndrome (PCOS) and its associated risk factors. A two-sample Mendelian randomization (MR) analysis was conducted. The genetic variations obtained from GWAS of individuals with European ancestry were found to be associated with the genetically predicted levels of Ca, Mg, Zn, Se, Fe, or ω-3. The data obtained from the FinnGen Consortium and MAGIC were utilized for the outcome of GWAS. The study found that there was a correlation between genetically predicted higher levels of Se and a reduced risk of insulin resistance, with a decrease of 2.2% according to random-effect IVW (OR 0.978, 95% CI 0.960-0.996, p = 0.015). The association between genetically determined mineral levels and PCOS was found to be limited, with an odds ratio (OR) ranging from 0.875 (95% CI: 0.637-1.202, p value = 0.411) for Ca. Limited scientific proof was found for the efficacy of other genetically determined mineral levels on hyperandrogenism, obesity, and insulin resistance. These findings suggested a causal relationship between genetically predicted higher levels of Se and a reduced risk of insulin resistance. Nonetheless, there is limited evidence supporting a causal association between various genetically determined mineral levels and the risk factors associated with PCOS.

References

Lee I, Sansone S, Irfan M, Copp T, Beidas R, Dokras A . Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers. F S Rep. 2022; 3(2):94-101. PMC: 9250120. DOI: 10.1016/j.xfre.2022.01.005. View

Guan C, Zahid S, Minhas A, Ouyang P, Vaught A, Baker V . Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease. Fertil Steril. 2022; 117(5):924-935. DOI: 10.1016/j.fertnstert.2022.03.009. View

Shojaeian Z, Sadeghi R, Latifnejad Roudsari R . Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ocvary syndrome: A systematic review and meta-analysis. Caspian J Intern Med. 2019; 10(4):359-369. PMC: 6856914. DOI: 10.22088/cjim.10.4.359. View

Bednarska S, Siejka A . The pathogenesis and treatment of polycystic ovary syndrome: What's new?. Adv Clin Exp Med. 2017; 26(2):359-367. DOI: 10.17219/acem/59380. View

Ibanez L, Oberfield S, Witchel S, Auchus R, Chang R, Codner E . An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6):371-395. DOI: 10.1159/000479371. View

Alesi S, Ee C, Moran L, Rao V, Mousa A . Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. Adv Nutr. 2021; 13(4):1243-1266. PMC: 9340985. DOI: 10.1093/advances/nmab141. View

Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T . Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol (Oxf). 2015; 83(6):888-94. DOI: 10.1111/cen.12840. View

Hamilton K, Zelig R, Parker A, Haggag A . Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome. Curr Dev Nutr. 2019; 3(11):nzz108. PMC: 6822014. DOI: 10.1093/cdn/nzz108. View

Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z . Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2015; 170(2):271-8. DOI: 10.1007/s12011-015-0480-7. View

10.

Martinez-Garcia M, Luque-Ramirez M, San-Millan J, Escobar-Morreale H . Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care. 2009; 32(8):1525-30. PMC: 2713652. DOI: 10.2337/dc09-0420. View

11.

Yang K, Zeng L, Bao T, Ge J . Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018; 16(1):27. PMC: 5870911. DOI: 10.1186/s12958-018-0346-x. View

12.

Davey Smith G, Ebrahim S . Data dredging, bias, or confounding. BMJ. 2002; 325(7378):1437-8. PMC: 1124898. DOI: 10.1136/bmj.325.7378.1437. View

13.

Zheng J, Baird D, Borges M, Bowden J, Hemani G, Haycock P . Recent Developments in Mendelian Randomization Studies. Curr Epidemiol Rep. 2017; 4(4):330-345. PMC: 5711966. DOI: 10.1007/s40471-017-0128-6. View

14.

Deshmukh H, Shah N, Papageorgiou M, Abdalla M, Lhaf F, Aye M . Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation study. Bone. 2021; 155:116285. DOI: 10.1016/j.bone.2021.116285. View

15.

Lawlor D . Commentary: Two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016; 45(3):908-15. PMC: 5005949. DOI: 10.1093/ije/dyw127. View

16.

OSeaghdha C, Wu H, Yang Q, Kapur K, Guessous I, Zuber A . Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet. 2013; 9(9):e1003796. PMC: 3778004. DOI: 10.1371/journal.pgen.1003796. View

17.

Evans D, Zhu G, Dy V, Heath A, Madden P, Kemp J . Genome-wide association study identifies loci affecting blood copper, selenium and zinc. Hum Mol Genet. 2013; 22(19):3998-4006. PMC: 3766178. DOI: 10.1093/hmg/ddt239. View

18.

Benyamin B, Esko T, Ried J, Radhakrishnan A, Vermeulen S, Traglia M . Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun. 2014; 5:4926. PMC: 4215164. DOI: 10.1038/ncomms5926. View

19.

Sun Q, Gao N, Xia W . Association between omega-3/6 fatty acids and cholelithiasis: A mendelian randomization study. Front Nutr. 2022; 9:964805. PMC: 9537577. DOI: 10.3389/fnut.2022.964805. View

20.

Locke A, Steinberg K, Chiang C, Service S, Havulinna A, Stell L . Exome sequencing of Finnish isolates enhances rare-variant association power. Nature. 2019; 572(7769):323-328. PMC: 6697530. DOI: 10.1038/s41586-019-1457-z. View